CAS
PTX

CTC Alternative Strategies’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

CTC Alternative Strategies’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,690
Closed -$152K – 248
2014
Q2 		$152K Buy
+1,690
New +$104K 0.13% 198

Other funds holding PTX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CTC Alternative Strategies's PTX Position: Q3 2014 in Review

CTC Alternative Strategies sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2014, closing a stake of 1,690 shares — an estimated $152K sold.

CTC Alternative Strategies first reported a position in PTX in Q2 2014 and held it in 1 quarter. The position peaked at $152K in Q2 2014. 83 funds tracked by Wall St. Rank hold PTX as of Q3 2014.

  • CTC Alternative Strategies reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2014 after selling out during the quarter.
  • CTC Alternative Strategies sold 1,690 Pernix Therapeutics Holdings, Inc. shares in Q3 2014, an estimated $152K.
  • CTC Alternative Strategies first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 1 quarter.
  • CTC Alternative Strategies's Pernix Therapeutics Holdings, Inc. position peaked at $152K in Q2 2014.
  • 83 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2014.

Based on CTC Alternative Strategies's 13F filing for Q3 2014, filed 14 Nov 2014.